Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024

Published on December 12, 2024

This report describes CDC's recommendation that all people aged ≥65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.

Continue reading on website
Other news

Surveillance Summaries: Intimate Partner Violence-Related Homicides of Hispanic and Latino Persons - National Violent Death Reporting System, United States, 2003-2021

December 10, 2024
This report describes data from the National Violent Death Reporting System on intimate partner violence-related homicides of Hispanic and Latino people in the United States from 2003-2021.

Notes from the Field: Geo-Temporal Trends in Fentanyl Administration Routes Among Adults Reporting Use of Illegally Manufactured Fentanyl When Assessed for Substance-Use Treatment - 14 U.S. States, 2017-2023

December 19, 2024
This report describes the percentage of people injecting illegally manufactured fentanyl by route of administration.